Hao Lu, Wenjia Lu, Yongwei Zhu, Chenchen Wang, Liming Shi, Xiaodan Li, . . . Manli Liu. (2020). Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe <i>Streptococcus suis</i> Infections. MDPI AG.
Chicago Style (17th ed.) CitationHao Lu, et al. Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe <i>Streptococcus Suis</i> Infections. MDPI AG, 2020.
MLA (9th ed.) CitationHao Lu, et al. Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe <i>Streptococcus Suis</i> Infections. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.